GRIP2 min read
GRIP2 min read
Julie DiMauro53 min listen
Other news includes the SEC ceasing its defenses of its climate disclosure rule, Fidelity launching its own stablecoin, and UBS limiting its size to skirt capital requirements.
GRIP2 min read
We explored how small and mid-sized pharmaceutical and biotech companies can avoid costly early compliance mistakes and minimize risk as they scale.
Alexander Barzacanos7 min read
CCO Jeff Lemay reflects on his time at Jazz Pharmaceuticals and asseses the road ahead for compliance and legal teams in the pharma sector.
Julie DiMauro5 min read
Final guidance clarifies FDA approach and addresses issues the industry raised regarding a draft version.
Julie DiMauro2 min read
The company failed to properly inform investors about regulatory challenges it was experiencing with the FDA.
Alexander Barzacanos2 min read
Two former executives were fined, but the company itself will not receive a civil penalty due to its self-reporting.
Alexander Barzacanos2 min read